This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Prognosis of meningococcal disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

It is important to recognise the patients who will progress from a non specific early presentation to severe disease since failure to initiate treatment rapidly will be fatal with the majority of deaths occurring in the first 24 hours (before specialist intervention) (1).

In early childhood, meningococcal disease is the leading infectious cause of death

  • it can be fatal within hours of the first symptoms appearing
  • the case fatality rate is about 10% (2)

The worst prognosis is said to be in patients who present with septic shock without meningitis (3).

Death in few people (with meningitis) is caused by raised intracranial pressure but the majority of deaths in meningococcal disease are due to shock or multi organ failure (3)

  • meningococcal septicaemia may progress rapidly to shock and circulatory collapse and the deterioration can be irreversible (4)

Features which predict poor prognosis at the time of presentation:

  • presence of shock
  • absence of meningism
  • rapidly progressive purpuric rash
  • low peripheral white blood cell count
  • thrombocytopenia
  • markedly deranged coagulation
  • depressed conscious level (3)

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.